HR22-00073
|
R-loop-mediated genome instability factors in cancer
|
Andrés Aguilera
|
Universidad de Sevilla
|
N/A
|
Oncology
|
Individual
|
500,000
|
HR22-00100
|
Using small-molecule inhibitors to explore the unique properties of the bacterial K+ machinery and its potential as an antibacterial target
|
João Morais Cabral
|
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação
|
N/A
|
Infectious disease
|
Individual
|
498,999
|
HR22-00123
|
Moving from reactive to proactive strategies for the prevention of the next West Nile virus outbreak in Andalucía
|
Jordi Figuerola
|
Consejo Superior de Investigaciones Científicas (CSIC)
|
N/A
|
Infectious disease
|
Individual
|
499,909.28
|
HR22-00172
|
(Epi)Genomic and microenvironment interactions driving evolution in chronic lymphocytic leukemia. Targets for clinical intervention
|
Elías Campo
|
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
|
Fundación Universidad de Oviedo; Centre de Regulació Genòmica (CRG)
|
Oncology
|
Research Consortium
|
999,806.30
|
HR22-00189
|
Neuromorphic devices for adaptive real-time neuromodulation in brain electrical stimulation therapies
|
Paulo Aguiar
|
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação
|
Universidade do Porto; Consejo Superior de Investigaciones Científicas (CSIC); Centro Hospitalar Universitário do Porto, E.P.E.
|
Enabling Technologies
|
Research Consortium
|
965,888.78
|
HR22-00221
|
Antibody-mediated NMDA receptor encephalitis: symptoms, biomarkers, and mechanisms of the prolonged recovery stage
|
Josep Dalmau
|
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
|
Fundació Privada per a la Recerca i la Docència Sant Joan de Déu
|
Neuroscience
|
Research Consortium
|
972,352.39
|
HR22-00253
|
Harnessing the adaptive immune response in vascular pathologies: towards the identification of new therapeutic avenues
|
Almudena R. Ramiro
|
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC
|
Fundación Instituto de Investigación Sanitaria of the Fundación Jiménez Díaz
|
Cardiovascular and associated metabolic diseases
|
Research Consortium
|
750,042.40
|
HR22-00316
|
Understanding and promoting the growth and regenerative functions of blood vessels in heart disease
|
Rui Benedito
|
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC
|
Centre de Regulació Genòmica (CRG); Fundació Institut de Recerca Contra la Leucèmia Josep Carreras; University Hospital RWTH Aachen
|
Cardiovascular and associated metabolic diseases
|
Research Consortium
|
999,948.04
|
HR22-00394
|
Epigenetic basis of gene-environment interactions underlying variation in Cognitive capabilities and their Decline with Age
|
Angel Barco
|
Consejo Superior de Investigaciones Científicas (CSIC)
|
N/A
|
Neuroscience
|
Individual
|
498,000
|
HR22-00395
|
Vascularized lymphoma on-chip: a multifaceted tool for translational research
|
Patricia Perez
|
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
|
European Molecular Biology Laboratory Barcelona
|
Enabling Technologies
|
Research Consortium
|
499,871.26
|
HR22-00402
|
Potentiating cancer immunotherapy by inhibiting the NMD quality-control pathway guided by genetic markers
|
Fran Supek
|
Fundació Institut de Recerca Biomèdica (IRB Barcelona)
|
Universitat Pompeu Fabra (UPF)
|
Oncology
|
Research Consortium
|
998,900.50
|
HR22-00405
|
Accelerated evolution of high-weight protein complexes for precision antimicrobials
|
Alfonso Jaramillo
|
Consejo Superior de Investigaciones Científicas (CSIC)
|
N/A
|
Enabling Technologies
|
Individual
|
482,730
|
HR22-00447
|
Metabolic communication between immune cells orchestrates the response to pathogens
|
Nuria Martínez
|
Consejo Superior de Investigaciones Científicas (CSIC)
|
N/A
|
Infectious disease
|
Individual
|
496,685.86
|
HR22-00529
|
Novel mutational mechanisms of somatic retrotransposition in the context of the 3D cancer genome
|
Jose Tubio
|
Universidad de Santiago de Compostela
|
N/A
|
Oncology
|
Individual
|
495,476.89
|
HR22-00533
|
A DIRect QuanTitative assessment of Heart disease with magnetic resonance imaging
|
Teresa Matias
|
Centro De Ciências Do Mar Do Algarve
|
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC; Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento; Universidad de Valladolid
|
Cardiovascular and associated metabolic diseases
|
Research Consortium
|
998,472.90
|
HR22-00551
|
Endothelial Cells as rheostats for Age-Related Diseases
|
Claudio Franco
|
Instituto de Medicina Molecular
|
N/A
|
Cardiovascular and associated metabolic diseases
|
Individual
|
499,818.88
|
HR22-00569
|
NRF2 as a novel therapeutic target in early and intermediate age-related macular degeneration
|
Miguel Seabra
|
Universidade Nova de Lisboa
|
Centro Investigation Biomedica en Redes Neurodegenerativas - CIBERNED
|
Neuroscience
|
Research Consortium
|
985,013
|
HR22-00602
|
New nanotechnological therapy for Parkinson´s disease: nose to brain delivery of GBA-polymer nanoconjugates
|
Marta Martínez
|
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)
|
Universitat Autònoma de Barcelona (UAB); Centro de Investigación Príncipe Felipe
|
Neuroscience
|
Research Consortium
|
599,723.00
|
HR22-00668
|
Uncovering the Differentiation Determinants and Dynamics of Congenital Susceptibility to Infections
|
Esteban Ballestar
|
Fundació Institut de Recerca Contra la Leucèmia Josep Carreras
|
Fundació Josep Carreras contra la Leucemia
|
Infectious disease
|
Individual
|
477,722.19
|
HR22-00681
|
Epigenetic regulation of host immunity and neurological long-term consequences of SARS-CoV-2 infection
|
Christian Brander
|
Institut de Recerca de la Sida "la Caixa" - IRSICAIXA
|
Centre de Regulació Genòmica (CRG); Fundació FLS de lluita contra la sida, les malalties infeccioses i la promoció de la salut i la ciencia; Institut De Recerca I Tecnología Agroalimentaria
|
Infectious disease
|
Research Consortium
|
999,580
|
HR22-00702
|
Multifunctional nano-immunotherapy against breast brain metastases
|
Helena Florindo
|
FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento
|
Tel Aviv University
|
Enabling Technologies
|
Research Consortium
|
853,405.70
|
HR22-00722
|
The BioPlaTTAR Platform for the Tailored and Rapid Development of Antiviral Biopharmaceuticals
|
Cláudio Manuel Soares
|
Universidade Nova de Lisboa
|
Instituto de Medicina Molecular; Fundação Calouste Gulbenkian; Consejo Superior de Investigaciones Científicas (CSIC)
|
Enabling Technologies
|
Research Consortium
|
1,000,000
|
HR22-00732
|
Somatic mutations and clonal hematopoiesis as predictors and drivers of heart failure progression
|
José Javier Fuster
|
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC
|
Fundació Institut de Recerca Contra la Leucèmia Josep Carreras; Fundació Institut d’Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP); Fundació Josep Carreras contra la Leucemia; Fundació Institut de Recerca Biomèdica (IRB Barcelona); Fundación para la Formación e Investigación Sanitarias de la Región de Murcia
|
Cardiovascular and associated metabolic diseases
|
Research Consortium
|
998,043.28
|
HR22-00737
|
Involvement of the gut microbiota-brain cross talk in the loss of eating control
|
Rafael Maldonado
|
Universitat Pompeu Fabra (UPF)
|
Institut D'Investigació Biomèdica De Girona (IDIBGI); Universitat Autònoma de Barcelona (UAB)
|
Neuroscience
|
Research Consortium
|
999,948.94
|
HR22-00741
|
Harnessing germinal centre regulation for improved vaccines
|
Luis Graca
|
Instituto de Medicina Molecular
|
Cultivamos Cultura
|
Infectious disease
|
Individual
|
499,952
|
HR22-00754
|
Role of diet-derived retinoids in CD8αα intraepithelial lymphocytes and intestinal defence at early-life
|
Manuela Ferreira
|
Universidade de Coimbra
|
N/A
|
Infectious disease
|
Individual
|
408,077.71
|
HR22-00776
|
Role of cellular senescence during breast cancer progression and treatment
|
Joaquín Arribas
|
Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)
|
N/A
|
Oncology
|
Individual
|
500,000
|
HR22-00778
|
Circuit mechanisms for associating high-order cortical activity with expected sensory representations in health and desease
|
Leopoldo Petreanu
|
Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud
|
N/A
|
Neuroscience
|
Individual
|
499,976.40
|
HR22-00799
|
T cell acute lymphoblastic leukemia: Origin & Relapse
|
Vera Sofia Correia Martins
|
Fundação Calouste Gulbenkian
|
Universität Ulm
|
Oncology
|
Research Consortium
|
681,932.54
|
HR22-00813
|
Highly efficient technology for clean and safe air: development of advanced air purifiers to inactivate pathogens in aerosols
|
Miguel A. Bañares
|
Consejo Superior de Investigaciones Científicas (CSIC)
|
Fundación para la Investigación Biomédica del Hospital Universitario La Paz; Hospital Universitario Severo Ochoa
|
Enabling Technologies
|
Research Consortium
|
997,000
|
HR22-00854
|
The dynamic membrane traffic at the neuronal synapse: Endosomal sub-compartments in health and disease
|
Ira Milosevic
|
Universidade de Coimbra
|
N/A
|
Neuroscience
|
Individual
|
492,837.85
|
HR22-00879
|
Whole-systems Analysis of the Microbiome-Metabolome Crosstalk for Biomarker Discovery and Therapy of Respiratory Fungal Diseases
|
Cristina Cunha
|
Universidade do Minho
|
N/A
|
Infectious disease
|
Individual
|
499,646.79
|
HR22-00890
|
Modulating nucleolar activity and stress responses as a therapeutic strategy in ALS
|
Oscar Fernandez-Capetillo
|
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III
|
N/A
|
Neuroscience
|
Individual
|
498,850
|